Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta Heparin
2. Beta-heparin
3. Chondroitin Sulfate B
4. Dermatan Sulfate
5. Sulfate B, Chondroitin
6. Sulfate, Dermatan
1. Dermatan Sulfate
2. Beta-heparin
3. Chondroitin Sulfate B
4. 24967-94-0
5. (2r,3s,4s,5r,6r)-6-[(2r,3r,4r,5r,6r)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate
6. Dermatan 4-sulfate
7. Desmin 370
8. Chondroitinsulfuric Acid
9. Dermatan Hydrogen Sulfate
10. Chondroitinsulfuric Acid B
11. Chondroitin Sulfate Type B
12. Mf 701 (polysaccharide)
13. Chondroitinsulfuric Acid Type B
14. Chondroitinsulfuric Acid, Type B
15. Chondroitinsulfuric Acids, Type B
16. Mf701
17. Dermatan, Hydrogen Sulfate (ester)
18. Einecs 246-552-8
19. Ds 435
20. Mf 701
21. Dermatan Sulfate, Low Molecular Weight
22. Dermatan 4'-sulfate
23. 54328-33-5
24. Dermatan Sulfate Polyanion
25. Chebi:58465
26. Yd58324
27. Danaparoid Sodium - Mixture Of Dermatan Sulfate, Heparan Sulfate And Chondroitin Sulfate
Molecular Weight | 475.4 g/mol |
---|---|
Molecular Formula | C14H21NO15S-2 |
XLogP3 | -4.3 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 5 |
Exact Mass | 475.06319014 g/mol |
Monoisotopic Mass | 475.06319014 g/mol |
Topological Polar Surface Area | 273 Ų |
Heavy Atom Count | 31 |
Formal Charge | -2 |
Complexity | 737 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
B - Blood and blood forming organs
B01 - Antithrombotic agents
B01A - Antithrombotic agents
B01AX - Other antithrombotic agents
B01AX04 - Dermatan sulfate
About the Company : Since its establishment in 1960 LDO has oriented its productions towards the extraction of active pharmaceutical ingredients from animal organs. Over the years, LDO has specialized...
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dermatan Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dermatan Sulfate, including repackagers and relabelers. The FDA regulates Dermatan Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dermatan Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dermatan Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dermatan Sulfate supplier is an individual or a company that provides Dermatan Sulfate active pharmaceutical ingredient (API) or Dermatan Sulfate finished formulations upon request. The Dermatan Sulfate suppliers may include Dermatan Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Dermatan Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dermatan Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dermatan Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Dermatan Sulfate DMFs exist exist since differing nations have different regulations, such as Dermatan Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dermatan Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Dermatan Sulfate USDMF includes data on Dermatan Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dermatan Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dermatan Sulfate suppliers with USDMF on PharmaCompass.
Dermatan Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dermatan Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dermatan Sulfate GMP manufacturer or Dermatan Sulfate GMP API supplier for your needs.
A Dermatan Sulfate CoA (Certificate of Analysis) is a formal document that attests to Dermatan Sulfate's compliance with Dermatan Sulfate specifications and serves as a tool for batch-level quality control.
Dermatan Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Dermatan Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dermatan Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dermatan Sulfate EP), Dermatan Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dermatan Sulfate USP).
LOOKING FOR A SUPPLIER?